|
Percent of targeted change achieved |
14-1. Cases of vaccine-preventable diseases
(1998, 2003) |
|
a. Congenital rubella syndrome: < 1 year |
86% - Moved toward target |
b. Diphtheria: < 35 years |
100% - Met target |
c. Haemophilus influenzae type B: < 5 years |
-59% - Moved away from target |
d. Hepatitis B: 2-18 years (1997, 2003) |
81% - Moved toward target |
e. Measles |
57% - Moved toward target |
f. Mumps |
67% - Moved toward target |
g. Pertussis: < 7 years |
-21% - Moved away from target |
h. Polio: wild virus type |
100% - Met target |
i. Rubella |
98% - Moved toward target |
j. Tetanus: < 35 years |
57% - Moved toward target |
k. Varicella: average annual number of cases, < 18 years (1999, 2001) |
53% - Moved toward target |
14-2. Cases of chronic hepatitis B infection: ≤ 2 years (1995, 2002) |
63% - Moved toward target |
14-3. Hepatitis B (1997, 2003) |
|
a. 19-24 years |
58% - Moved toward target |
b. 25-39 years |
41% - Moved toward target |
c. 40+ years |
67% - Moved toward target |
d. Injection drug users |
75% - Moved toward target |
e. Heterosexually active persons |
61% - Moved toward target |
f. Men who have sex with men |
-8% - Moved away from target |
g. Occupationally exposed workers |
110% - Met target |
14-4. Bacterial meningitis: 1-23 months (1998, 2002) |
114% - Met target |
14-5. Invasive pneumococcal infections (1997, 2002) |
|
a. < 5 years |
171% - Met target |
b. 65+ years |
95% - Moved toward target |
14-5. Invasive penicillin-resistant pneumococcal infections |
|
c. < 5 years |
110% - Met target |
d. 65+ years |
-200% - Moved away from target |
14-6. Hepatitis A (1997, 2003) |
125% - Met target |
14-7. Meningococcal disease (1997, 2002) |
267% - Met target |
14-8. Lyme disease (1992–96, 2002) |
-196% - Moved away from target |
14-9. Hepatitis C (1997, 2003) |
60% - Moved toward target |
14-11. Tuberculosis (1998, 2003) |
29% - Moved toward target |
14-12. Curative therapy for tuberculosis (1996, 2000) |
38% - Moved toward target |
14-16. Invasive early onset group B streptococcal disease (1996, 2002) |
120% - Met target |
14-17. Peptic ulcer hospitalizations (1998, 2002) |
32% - Moved toward target |
14-18. Antibiotics prescribed for ear infections: < 5 years (1996–97, 2001) |
77% - Moved toward target |
14-19. Antibiotics prescribed for the common cold
(1996–97, 2001) |
55% - Moved toward target |
14-20. ICU patients (1998, 2003) |
|
a. Catheter-associated urinary tract infection |
120% - Met target |
b. Central line-associated bloodstream infection |
120% - Met target |
Infants weighing 1,000 grams or less in NICUs |
|
d. Central line-associated bloodstream infection (1995–98, 2002) |
133% - Met target |
14-22. Immunizations: 19-35 months (1998, 2003) |
|
a. DTaP vaccine: 4 doses |
17% - Moved toward target |
b. Haemophilus influenzae type B vaccine: 3 doses |
100+% - Met target |
c. Hepatitis B vaccine: 3 doses |
167% - Met target |
d. MMR vaccine: 1 dose |
100+% - Met target |
e. Polio vaccine: 3 doses |
100+% - Met target |
f. Varicella vaccine: 1 dose |
89% - Moved toward target |
g. PCV vaccine: 4 doses (2002, 2003) |
14% - Moved toward target |
14-23. Immunizations: day care (1997–98, 2001) |
|
a. DTaP coverage |
100% - Met target |
b. MMR coverage |
117% - Met target |
c. Polio vaccine coverage |
100% - Met target |
14-24a. Fully immunized: 19-35 months (1998, 2002) |
29% - Moved toward target |
14-25. Childhood vaccine coverage tracked by |
|
a. Public health providers (1999, 2001) |
40% - Moved toward target |
b. Private providers (1999, 2001) |
39% - Moved toward target |
14-26. Children in population-based immunization registries (1999, 2002) |
59% - Moved toward target |
14-27. Immunizations: 13-15 years (1997, 2003) |
|
a. Hepatitis B vaccine: 3+ doses |
79% - Moved toward target |
b. MMR vaccine: 2+ doses |
400% - Met target |
c. Tetanus-diphtheria booster: 1+ doses |
100+% - Met target |
d. Varicella vaccine: 1+ doses |
71% - Moved toward target |
14-28. Hepatitis B vaccination coverage |
|
a. Long-term hemodialysis patients
(1995, 2001) |
46% - Moved toward target |
b. Men who have sex with men
(1994–99, 1998–2000) |
8% - Moved toward target |
c. Occupationally exposed workers
(1995, 2003) |
31% - Moved toward target |
14-29. Noninstitutionalized: 65+ years (1998, 2003) |
|
a. Influenza vaccination in past year |
8% - Moved toward target |
b. Pneumococcal vaccination ever received |
23% - Moved toward target |
Noninstitutionalized high-risk: 18-64 years |
|
c. Influenza vaccination in past year |
6% - Moved toward target |
d. Pneumococcal vaccination ever received |
6% - Moved toward target |
14-29. Institutionalized: 18+ years (1997, 1999) |
|
e. Influenza vaccination in past year |
23% - Moved toward target |
f. Pneumococcal vaccination ever received |
20% - Moved toward target |
14-30a. Vaccine-associated paralytic polio (1997, 2000) |
100% - Met target |
14-30b. Febrile seizures following pertussis vaccination (1998, 2001) |
129% - Met target |
14-31a. Active surveillance for vaccine safety (1999, 2000) |
29% - Moved toward target |
Tracking data for objectives 14-10, 14-13, 14-14, 14-20c and e, 14-21, 14-22h, 14-23d through l, 14-24b, 14-29g, and 14-31b are unavailable. Objective 14-15 was deleted at the midcourse.
Years in parentheses represent the baseline data year and the most recent data year used to compute the percent of the Healthy People 2010 target achieved.
* Percent of target achieved cannot be calculated.
1 The most recent value is 94%; the baseline value is 93%; the target value is 90%.
2 The most recent value is 93%; the baseline value is 92%; the target value is 90%.
3 The most recent value is 92%; the baseline value is 91%; the target value is 90%.
4 The most recent value is 91%; the baseline value is 93%; the target value is 90%.